Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Supratentorial Neoplasms 1Epilepsy 1Arteriovenous Malformations 1Aneurysm 1

Interventions

Temozolomide 163Radiosurgery 129Radiotherapy 107Bevacizumab 98Magnetic Resonance Spectroscopy 75Carboplatin 48Surgical Procedures, Operative 35pembrolizumab 34Radiation 34Etoposide 34Nivolumab 33Irinotecan 33Cyclophosphamide 33Erlotinib Hydrochloride 31Carmustine 28Lomustine 26Trastuzumab 25Cisplatin 25Ipilimumab 24Filgrastim 23Mental Status and Dementia Tests 21Magnetic Resonance Imaging 21Aminolevulinic Acid 21Vincristine 20Surveys and Questionnaires 19Capecitabine 19Topotecan 18Specimen Handling 18Pemetrexed 18Radiotherapy, Intensity-Modulated 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brain Neoplasms × Bupivacaine × CNS × Clear all
NCT03177252 2020-10-22

Scalp block

Washington University School of Medicine

Phase 1 Withdrawn
CNS

Brain Neoplasms

NCT00972790 2012-03-01

Scalp Nerve Blocks for Post-Craniotomy Pain

Unity Health Toronto

Phase NA Completed
89 enrolled
CNS

Aneurysm, Arteriovenous Malformations, Brain Neoplasms, Epilepsy, Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡